Wednesday, February 15, 2023 9:22:25 AM
2023-02-14 18:31
Fintel reports that Armistice Capital has filed a 13G/A form with the SEC disclosing ownership of 17.00MM shares of Spectrum Pharmaceuticals, Inc. (SPPI). This represents 8.37% of the company.
In their previous filing dated February 15, 2022 they reported 9.67MM shares and 5.90% of the company, an increase in shares of 75.88% and an increase in total ownership of 2.47% (calculated as current - previous percent ownership).
The projected annual revenue for Spectrum Pharmaceuticals is $46MM, a decrease of 57.97%. The projected annual EPS is -$0.26.
https://fintel.io/news/armistice-capital-now-owns-837-of-spectrum-pharmaceuticals-sppi-858
Wonder, why a decrease of 58%? Were they projecting $100M? Is it about lost Poziotinib revenue?
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM